COMMUNIQUÉS West-GlobeNewswire

First-Half 2026 results confirm commercial and operational resilience in a challenging market environment - Transformation progressing as planned, including the divestment of the Brindisi site
29/07/2026
Press Release Paris, 29th July 2026 €356.5 million Net Sales, down 13.5% year-on-year as reported and -11.8% on a comparative basis 1 As expected, including a negative €13 million impact from the planned discontinuation [...]
Ipsen nominates Catherine Bradley to its Board of Directors as independent Director
29/07/2026
Ipsen appoints Catherine Bradley as independent Director to its Board of Directors PARIS, FRANCE, 29 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Catherine Bradley, CBE, as an [...]
F6S Ranks Life Backup Plan 55th in Health and Wellness
29/07/2026
National ranking accompanies recognition from Pepperdine, TiE, ASCEND LA and two healthcare publications Aliso Viejo, CA, July 29, 2026 (GLOBE NEWSWIRE) -- F6S ranks Life Backup Plan® 55th on its, “ 100 Top Health [...]
MediWound to Report Second Quarter 2026 Financial Results
29/07/2026
MediWound to Report Second Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Thursday, August 13 at 8:30 a.m. Eastern Time YAVNE, Israel, July 29, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global [...]
The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy
29/07/2026
--Independent Peer Review Provides External Validation of the Trial's Design, Statistical Methodology and Findings-- --Randomized, Double-Blind, Placebo-Controlled HOPE-3 Phase 3 Trial (n=106) Met Primary Endpoint, with [...]
Alvotech announces successful closure of FDA inspection of manufacturing facility
29/07/2026
REYKJAVIK, ICELAND (July 29, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
TimelyCare Sets New Standard for Student Safety with URAC Artificial Intelligence in Healthcare Accreditation
29/07/2026
Independent review validates the governance, safeguards and accountability supporting TimelyCare’s responsible use of AI Fort Worth, TX, July 29, 2026 (GLOBE NEWSWIRE) -- Prioritizing student safety and well-being in [...]
Acentra Health Names Srini Surendranath as Senior Vice President of Product and Solutions Management
29/07/2026
New leadership role strengthens product innovation and solutions strategy to accelerate growth and deliver greater value for clients MCLEAN, Va., July 29, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and [...]
PROLLENIUM® Expands PACE with Launch of Eight New Clinical Education Modules
29/07/2026
New modules, developed with Harley Academy, extend the PACE Training & Education Portal across foundational and advanced clinical techniques RICHMOND HILL, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- PROLLENIUM® , a [...]
Hyperion DeFi Schedules First Quarter Earnings Call for Wednesday, August 12 at 5:00 p.m. ET
29/07/2026
LAGUNA HILLS, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it [...]
Jushi Holdings Provides Update on Plan of Arrangement
29/07/2026
BOCA RATON, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“ Jushi ” or the “ Company ”) ( CSE: JUSH ) ( OTCQX: JUSHF ) , a vertically integrated, multi-state cannabis operator, announces that, further to [...]
BPC-157 Introduced by Kylo Peptides for Laboratory Research Purposes
29/07/2026
Sheridan, Wyoming, July 29, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides, a United States research peptide supplier, today announced the addition of BPC-157 to its catalog of research compounds. The synthetic peptide is [...]
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma
29/07/2026
FDA Granted RMAT Designation Based on ALPHA3 Trial Futility Analysis, Highlighting Cema-Cel’s Potential to Transform Disease Treatment in First-Line LBCL Consolidation Cema-Cel Induced Rapid and Substantial MRD [...]
Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons
29/07/2026
Exclusive Partnership Offers The Maidstone Guests Access and Savings on Flyte's Private Travel Services Collaboration Marks the Beginning of a Long-Term Relationship Connecting Luxury Hospitality with Modern Private [...]
Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights
29/07/2026
Akebia to Host Conference Call on August 5 at 4:30 p.m. EDT CAMBRIDGE, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the [...]
Noom Health partners with Levrx to bring personalized weight management support into the pharmacy benefits experience
29/07/2026
PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Noom Health, the enterprise arm of Noom and a leading behavior change platform, today announced a new integration with Levrx Technology, a pharmacy navigation and [...]
Realize Medical Appoints Chris Marrus to Board of Directors
29/07/2026
Surgical robotics and medtech commercialization veteran joins Realize Medical's board as the company scales Elucis, its FDA-cleared VR surgical planning platform OTTAWA, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- [...]
UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026
29/07/2026
Conference Call and Webcast Scheduled for Wednesday, August 5th, 2026, at 10:00 AM ET PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and [...]
LB Pharmaceuticals Announces $150 Million Private Placement
29/07/2026
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]

Pages